Medical devices for the treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders; medical devices for prostate, bladder and/or kidney related treatments, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical apparatus for the non-surgical treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders, comprised of stents, probes, obturators, temporary or permanent artificial implants, and catheters; catheter-type medical device for the therapeutic treatment of benign prostatic hyperplasia (BPH) and other urological disease states; medical devices for prostate tissue ablation or destruction, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical devices for use in tissue ablation, and the treatment of prostate cancer, kidney or renal tumors, and benign prostatic hyperplasia (BPH); medical apparatus and instruments for treating urological conditions and diseases in humans, namely, a medical device that provides a port-like access to the kidneys, ureters, bladder, or urethra of patients to allow access and drainage of the urinary system; medical device, namely, a stent, temporary or permanent artificial implants, for placement in the urethra or prostate intended for removing prostate tissue through the urethra; medical devices, namely, stents, probes, obturators, temporary or permanent artificial implants, and catheters used to dilate strictured areas of the urethra